About EmergingMed
EmergingMed is a Healthcare company based in Durham (United States) founded in 2000. Cloud based platform to match patients with clinical trials. EmergingMed has raised $3 million across 1 funding round from investors including Rand Capital, Advantage Capital and Florida Gulfshore Capital. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its competitors include Deep Lens, Inteliquet and Wild Type Advocates; 2 of its 3 listed competitors have raised funding.
Company details
EmergingMed was founded in 2000 and is headquartered in Durham, United States. A cloud-based platform is operated to connect cancer patients with suitable clinical trials based on diagnosis, stage, symptoms, and treatment history. Clinical Trial Navigators are provided to assist families in searching for trials, contacting sites, and accessing support services within the healthcare sector focused on patient engagement.
- Headquarters Durham, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Website emergingmed.com
- Social LinkedIn X
- Total Equity Funding$3M (USD)
in 1 rounds
- Latest Funding Round$3M (USD), Series B
Jan 2006
- InvestorsRand Capital
& 3 more
Funding Insights of EmergingMed
EmergingMed has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series B round of $3 million completed in January 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 1
- Last Round Series B — $3M
- First Round $3M
(Jan 2006)
- Investors Count 4
All 1 funding rounds of EmergingMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2006 | $3M | Series B | – | Advantage Capital, Rand Capital | – |
4 investors in total: 4 institutional.
Investors in EmergingMed
EmergingMed has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Rand Capital, Advantage Capital and Florida Gulfshore Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | advantagecap.com | New Orleans, United States | ||
Early & Growth stage VC Firm investing primarily in the US | 1969 | randcapital.com | Buffalo, United States | |
Early stage venture opportunities are targeted by the firm. | gulfshorecap.com | Naples, United States | ||
A single-family office with diverse investment portfolios is operated. | 2002 | spring-bay.com | Ponte Vedra Beach, United States |
Investor details for EmergingMed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of EmergingMed
2 dated milestones of EmergingMed across 6 years, from founding to its latest funding, stage changes and deals.
- Founded EmergingMed is founded.
- Funding First funding round of $3.0M.
Competitors of EmergingMed
EmergingMed has 3 listed competitors in our database, 2 of them funded. They include Deep Lens, Inteliquet and Wild Type Advocates.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| deeplens.ai | 2017 | Columbus, United States | $17.2M | AI and cloud-based digital pathology platform is developed. | ||
| inteliquet.com | 2010 | Dover, United States | $14.6M | Clinical trial management and analytics services for pharmaceuticals are provided. | ||
| wildtypeadvocates.com | 2022 | United States | Wild Type Advocates provides AI-based medical information and comprehensive solutions for oncology care. |
Detailed competitors of EmergingMed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EmergingMed
The website of EmergingMed (emergingmed.com) receives about 2.7K visits a month and ranks #3,248,647 among all websites worldwide, #4,265 in Biotechnology and Pharmaceuticals.
- Monthly visits2.7K
▼ 7.6% vs previous month
- Unique visitors1.5K
per month
- Global rank#3,248,647
among all websites
- Category rank#4,265
Health · Biotechnology and Pharmaceuticals
- Bounce rate28%
- Pages per visit7.0
- Average visit14 min 19 sec
- DevicesDesktop 16% · Mobile 84%
Websites whose visitors overlap most with EmergingMed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centerwatch.com | 100% | 158.2K | #254,725 | View details | |
cancertrialshelp.org | cancertrialshelp.org | 100% | – | ||
controlled-trials.com | controlled-trials.com | 74% | – | ||
targittrial.com | targittrial.com | 73% | – | ||
eurocare.it | eurocare.it | 73% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 29 similar websites and full traffic analytics for EmergingMed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 29 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as EmergingMed (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EmergingMed
EmergingMed was founded in 2000 and raised its 1st funding round 6 years after it was founded.
EmergingMed is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
EmergingMed is a funded company, having raised a total of $3M across 1 funding round to date. The company's 1st funding round was a Series B of $3M, raised on Jan 2006.
EmergingMed was founded in 2000 and is headquartered in Durham, United States. A cloud-based platform is operated to connect cancer patients with suitable clinical trials based on diagnosis, stage, symptoms, and treatment history. Clinical Trial Navigators are provided to assist families in searching for trials, contacting sites, and accessing support services within the healthcare sector focused on patient engagement.
EmergingMed's top competitors include Deep Lens, Inteliquet and Wild Type Advocates.
EmergingMed has 4 investors. Key investors include Rand Capital, Advantage Capital, Florida Gulfshore Capital, and Spring Bay Companies.